they are trying Child Spacing a fairly big

they are trying Child Spacing a fairly big

various factors Child Spacing it also includes
 
Photo :Child Spacing

within your means Home Getting Pregnant Preparing for Pregnancy Child Spacing Child Spacing Planning to have more children and deciding when to have them is a big decision. It is something that a couple should decide together, basing it on their family needs and lifestyle. Raising two or three children is a big responsibility and it affects a woman, her partner and the rest of the family. So, before having more children, it is important to understand and recognize the problems and pleasures each child will bring to family life. One the other side of the equation, it is said that there is seldom an ideal time for having a child. If couples waited for the perfect time to have a baby, they would probably end up with two instead of five. Allowing Time Between Children Having children one after another (within a year) puts a lot of strain and tension on the mother. Most of the time, in these cases, miscarriages, low birth weight , and premature births are likely to happen. The mother's health may also be affected during this time because of the high demands and attention the second baby will need. Therefore, doctors suggest that women wait at least 18 to 23 months after a full-term birth before conceiving again. Child spacing varies from family to family. A lot has to do with the family situation, including parental issues. Some considerations have to do with the temperament of the children while others deal with developmental needs of children at different ages. All of these aspects enter into the spacing decision. Two, Three or Four Years Can Be Good Additionally, if the baby is a very high-need infant who requires a lot of time and energy from the mother, additional space is a good idea. A two or three year gap between a high need infant and another child avoids parent burnout and allows time for the needs of the infant to be fulfilled before a competitor arrives on the scene. Parents with children three to four years apart feel that they can give each child more individualized attention. When there is a bigger gap the older sibling is more able to take care of the younger sibling. This may make the older child feel important. Older siblings can revisit younger types of play while younger children, who always love to do what their older siblings do, can play and learn with the older children. There are other advantages to spacing children farther apart. Along with getting to know one child before another arrives, it allows time for a woman to regain her pre-pregnancy body as well as rediscovering herself before becoming consumed with another newborn. Having Children Close Together If the baby is easy, then closer spacing works well because an in-house playmate is available. Some mothers feel that closely spaced children bond deeply and therefore, see a benefit to spacing children close together. Many feel that they can attend the same preschool, be each other's playmates and grow up very close. And, they all agree that there is less sibling rivalry. The years that a woman is in "baby mode" are consolidated since she's already set up for diapers, baby-proofing - and the adjustment to baby-time is already in place. The rhythm is established in the home and things continue to tick along without having to readjust too much when a new baby arrives. But spacing your children close together has its drawbacks as well. Children in the first three years of their lives have relatively high needs in terms of attention and care. Babies and toddlers need constant supervision and the responsibilities are round-the-clock. The good news is that there are many kinds of support available to ease the workload of a having children close together. Family, friends, resources like parenting groups and quality childcare are all available for mothers with busy lives. Whatever the case - close together or spaced far apart - to have children is a blessing no matter how many and when you have them. Login to comment Log in or sign up Forgot Password? Username: Password: CANCEL (0 Comments) Login to add a comment Post a comment You must be logged in to comment. you really


purported to Child Spacing and you're going
bring together Diuril Injection profits

bring together Diuril Injection profits

ability Diuril Injection without borderlines
 
Photo :Diuril Injection

destructive Diuril Injection Generic Name: Sodium Diuril - chlorothiazide Dosage Form: injection Overview Side Effects Dosage Professional Interactions More Pregnancy Warnings Breastfeeding Warnings User Reviews Drug Images Support Group Q & A Pricing & Coupons Intravenous Sodium Diuril (chlorothiazide sodium) Rx only Slideshow FDA-Approved Weight Loss Drugs: Can They Help You? DESCRIPTION Intravenous Sodium DIURIL (chlorothiazide sodium) is a diuretic and antihypertensive. It is 6-chloro-2 H -1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide monosodium salt and its molecular weight is 317.71. Its empirical formula is C 7 H 5 ClN 3 NaO 4 S 2 and its structural formula is: Intravenous Sodium DIURIL is a sterile lyophilized white powder and is supplied in a vial containing: Chlorothiazide sodium equivalent to chlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.5 g Inactive ingredients: Mannitol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.25 g Sodium hydroxide to adjust pH. DIURIL (chlorothiazide) is a diuretic and antihypertensive. It is 6-chloro-2 H -1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Its empirical formula is C 7 H 6 ClN 3 O 4 S 2 and its structural formula is: It is a white, or practically white, crystalline powder with a molecular weight of 295.72, which is very slightly soluble in water, but readily soluble in dilute aqueous sodium hydroxide. It is soluble in urine to the extent of about 150 mg per 100 mL at pH 7. CLINICAL PHARMACOLOGY The mechanism of the antihypertensive effect of thiazides is unknown. DIURIL (chlorothiazide) does not usually affect normal blood pressure. DIURIL (chlorothiazide) affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosage all thiazides are approximately equal in their diuretic efficacy. DIURIL (chlorothiazide) increases excretion of sodium and chloride in approximately equivalent amounts. Natriuresis may be accompanied by some loss of potassium and bicarbonate. After oral use diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours. Following intravenous use of Sodium DIURIL, onset of the diuretic action occurs in 15 minutes and the maximal action in 30 minutes. Pharmacokinetics and Metabolism DIURIL is not metabolized but is eliminated rapidly by the kidney; 96 percent of an intravenous dose is excreted unchanged in the urine within 23 hours. The plasma half-life of chlorothiazide is 45-120 minutes. Chlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk. INDICATIONS AND USAGE Intravenous Sodium DIURIL is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Intravenous Sodium DIURIL has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Use in Pregnancy Routine use of diuretics during normal pregnancy is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy and there is no satisfactory evidence that they are useful in the treatment of toxemia. Edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. Thiazides are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy (see PRECAUTIONS, Pregnancy ). Dependent edema in pregnancy, resulting from restriction of venous return by the gravid uterus, is properly treated through elevation of the lower extremities and use of support stockings. Use of diuretics to lower intravas-cular volume in this instance is illogical and unnecessary. During normal pregnancy there is hypervolemia which is not harmful to the fetus or the mother in the absence of cardiovascular disease. However, it may be associated with edema, rarely generalized edema. If such edema causes discomfort, increased recumbency will often provide relief. Rarely this edema may cause extreme discomfort which is not relieved by rest. In these instances, a short course of diuretic therapy may provide relief and be appropriate. CONTRAINDICATIONS Anuria. Hypersensitivity to any component of this product or to other sulfonamide-derived drugs. WARNINGS Intravenous use in infants and children has been limited and is not generally recommended. Use with caution in severe renal disease. In patients with renal disease, thiazides may precipitate azotemia. Cumulative effects of the drug may develop in patients with impaired renal function. Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma. Thiazides may add to or potentiate the action of other antihypertensive drugs. Sensitivity reactions may occur in patients with or without a history of allergy or bronchial asthma. The possibility of exacerbation or activation of systemic lupus erythematosus has been reported. Lithium generally should not be given with diuretics (see PRECAUTIONS, Drug Interactions ). PRECAUTIONS General All patients receiving diuretic therapy should be observed for evidence of fluid or electrolyte imbalance: namely, hyponatremia, hypochloremic alkalosis, and hypokalemia. Serum and urine electrolyte determinations are particularly important when the patient is vomiting excessively or receiving parenteral fluids. Warning signs or symptoms of fluid and electrolyte imbalance, irrespective of cause, include dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, confusion, seizures, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting. Hypokalemia may develop especially with brisk diuresis, when severe cirrhosis is present or after prolonged therapy. Interference with adequate oral electrolyte intake will also contribute to hypokalemia. Hypokalemia may cause cardiac arrhythmias and may also sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). Hypokalemia may be avoided or treated by use of potassium-sparing diuretics or potassium supplements such as foods with a high potassium content. Although any chloride deficit is generally mild and usually does not require specific treatment except under extraordinary circumstances (as in liver disease or renal disease), chloride replacement may be required in the treatment of metabolic alkalosis. Dilutional hyponatremia may occur in edematous patients in hot weather; appropriate therapy is water restriction, rather than administration of salt, except in rare instances when the hyponatremia is life-threatening. In actual salt depletion, appropriate replacement is the therapy of choice. Hyperuricemia may occur or acute gout may be precipitated in certain patients receiving thiazides. In diabetic patients dosage adjustments of insulin or oral hypoglycemic agents may be required. Hyperglycemia may occur with thiazide diuretics. Thus latent diabetes mellitus may become manifest during thiazide therapy. The antihypertensive effects of the drug may be enhanced in the postsympathectomy patient. If progressive renal impairment becomes evident, consider withholding or discontinuing diuretic therapy. Thiazides have been shown to increase the urinary excretion of magnesium; this may result in hypo-magnesemia. Thiazides may decrease urinary calcium excretion. Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. Marked hypercalcemia may be evidence of hidden hyperparathyroidism. Thiazides should be discontinued before carrying out tests for parathyroid function. Increases in cholesterol and triglyceride levels may be associated with thiazide diuretic therapy. Laboratory Tests Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be done at appropriate intervals. Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics. Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur. Antidiabetic drugs - (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required. Other antihypertensive drugs - additive effect or potentiation. Corticosteroids, ACTH - intensified electrolyte depletion, particularly hypokalemia. Pressor amines (e.g., norepinephrine) - possible decreased response to pressor amines but not sufficient to preclude their use. Skeletal muscle relaxants, nondepolarizing (e.g., tubocurarine) - possible increased responsiveness to the muscle relaxant. Lithium - generally should not be given with diuretics. Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity. Refer to the package insert for lithium preparations before use of such preparations with Sodium DIURIL. Non-steroidal Anti-inflammatory Drugs - In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. Therefore, when Sodium DIURIL and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained. Drug/Laboratory Test Interactions Thiazides should be discontinued before carrying out tests for parathyroid function (see PRECAUTIONS, General ). Carcinogenesis, Mutagenesis, Impairment of Fertility Carcinogenicity studies have not been conducted with chlorothiazide. Chlorothiazide was not mutagenic in vitro in the Ames microbial mutagen test (using a maximum concentration of 5 mg/plate and Salmonella typhimurium strains TA98 and TA100) and was not mutagenic and did not induce mitotic nondisjunction in diploid-strains of Aspergillus nidulans . Chlorothiazide had no adverse effects on fertility in female rats at doses up to 60 mg/kg/day and no adverse effects on fertility in male rats at doses up to 40 mg/kg/day. These doses are 1.5 and 1.0 times** the recommended maximum human dose, respectively, when compared on a body weight basis. Pregnancy Teratogenic Effects - Pregnancy Category C: Although reproduction studies performed with chlorothiazide doses of 50 mg/kg/day in rabbits, 60 mg/kg/day in rats and 500 mg/kg/day in mice revealed no external abnormalities of the fetus or impairment of growth and survival of the fetus due to chlorothiazide, such studies did not include complete examinations for visceral and skeletal abnormalities. It is not known whether chlorothiazide can cause fetal harm when administered to a pregnant woman; however, thiazides cross the placental barrier and appear in cord blood. DIURIL should be used during pregnancy only if clearly needed (see INDICATIONS AND USAGE ). Nonteratogenic Effects: Chlorothiazide may cause fetal or neonatal jaundice, thrombocytopenia, and possibly other adverse reactions which have occurred in the adult. Nursing Mothers Because of the potential for serious adverse reactions in nursing infants from Intravenous Sodium DIURIL, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Pediatric Use Safety and effectiveness of Intravenous Sodium DIURIL in pediatric patients have not been established. Geriatric Use Clinical studies of Intravenous Sodium DIURIL did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function (see WARNINGS ). Adverse Reactions The following adverse reactions have been reported and, within each category, are listed in order of decreasing severity. Body as a Whole: Weakness. Cardiovascular: Hypotension including orthostatic hypotension (may be aggravated by alcohol, barbiturates, narcotics or antihypertensive drugs). Digestive: Pancreatitis, jaundice (intrahepatic cholestatic jaundice), diarrhea, vomiting, sialadenitis, cramping, constipation, gastric irritation, nausea, anorexia. Hematologic: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia. Hypersensitivity: Anaphylactic reactions, necrotizing angiitis (vasculitis and cutaneous vasculitis), respiratory distress including pneumonitis and pulmonary edema, photosensitivity, fever, urticaria, rash, purpura. Metabolic: Electrolyte imbalance (see PRECAUTIONS ), hyperglycemia, glycosuria, hyperuricemia. Musculoskeletal: Muscle spasm. Nervous System/Psychiatric: Vertigo, paresthesias, dizziness, headache, restlessness. Skin: Erythema multiforme including Stevens-Johnson syndrome, exfoliative dermatitis including toxic epidermal necrolysis, alopecia. Special Senses: Transient blurred vision, xanthopsia. Renal: Renal failure, renal dysfunction, interstitial nephritis, (see WARNINGS ); hematuria (following intravenous use). Urogenital: Impotence. Whenever adverse reactions are moderate or severe, thiazide dosage should be reduced or therapy withdrawn. To report SUSPECTED ADVERSE REACTIONS, contact Oak Pharmaceuticals, Inc. at 1-800-932-5676 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. OVERDOSAGE The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias. In the event of overdosage, symptomatic and supportive measures should be employed. Correct dehydration, electrolyte imbalance, hepatic coma and hypotension by established procedures. If required, give oxygen or artificial respiration for respiratory impairment. The degree to which chlorothiazide sodium is removed by hemodialysis has not been established. The intravenous LD 50 of chlorothiazide in the mouse is 1.1 g/kg. DOSAGE AND ADMINISTRATION Intravenous Sodium DIURIL should be reserved for patients unable to take oral medication or for emergency situations. Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response. Intravenous use in infants and children has been limited and is not generally recommended. When medication can be taken orally, therapy with DIURIL tablets or oral suspension may be substituted for intravenous therapy, using the same dosage schedule as for the parenteral route. Intravenous Sodium DIURIL may be given slowly by direct intravenous injection or by intravenous infusion. Extravasation must be rigidly avoided. Do not give subcutaneously or intramuscularly. The usual adult dosage is 0.5 to 1 g once or twice a day. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on three to five days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely to occur. Directions for Reconstitution Use aseptic technique. Because Intravenous Sodium DIURIL contains no preservative, a fresh solution should be prepared immediately prior to each administration, and the unused portion should be discarded. Add 18 mL of Sterile Water for Injection to the vial to form an isotonic solution for intravenous injection. Never add less than 18 mL. When reconstituted with 18 mL of Sterile Water, the final concentration of Intravenous Sodium DIURIL is 28 mg/mL. The reconstituted solution is clear and essentially free from visible particles. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use whenever solution and container permit. The solution is compatible with dextrose or sodium chloride solutions for intravenous infusion. Avoid simultaneous administration of solutions of chlorothiazide with whole blood or its derivatives. HOW SUPPLIED Intravenous Sodium DIURIL is a dry, sterile lyophilized white powder usually in plug form, supplied in vials containing chlorothiazide sodium equivalent to 0.5 g of chlorothiazide. NDC 76478-711-40. Storage Store at 20-25 C (68-77 F). See USP controlled room temperature. For single dose only. Use solution immediately after reconstitution (see DOSAGE AND ADMINISTRATION, Directions for Reconstitution ). Discard unused portion of the reconstituted solution. AKORN Distributed by: Akorn, Inc. Lake Forest, IL 60045 OAK Mfd. for: Oak Pharmaceuticals, Inc. Registered trademark of Merck & Co., Inc. Whitehouse Station, NJ 08889, U.S.A. ** Calculations based on a human body weight of 50 kg. OPCH00N Rev. 05/12 750-06619-1 Principal Display Panel Text for Container Label: NDC 76478-711-40 Single Dose Vial Intravenous Sodium Diuril (chlorothiazide sodium) 0.5 g Chlorothiazide Equivalent Rx only Oak Logo Principal Display Panel Text for Carton Label: NDC 76478-711-40 12 Vials Intravenous Rx only Sodium Diuril (chlorothiazide sodium) 0.5 g Chlorothiazide Equivalent For preparation of Intravenous Solutions Store at 20-25 C (68-77 F). See USP Controlled Room Temperature Oak Logo SODIUM DIURIL chlorothiazide sodium injection Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:76478-711 Route of Administration INTRAVENOUS DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength chlorothiazide sodium (chlorothiazide) chlorothiazide 0.5 mg in 18 mL Inactive Ingredients Ingredient Name Strength mannitol sodium hydroxide Packaging # Item Code Package Description 1 NDC:76478-711-40 12 VIAL (12 VIAL) in 1 CARTON 1 18 mL in 1 VIAL Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA011145 10/03/1958 Labeler - Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) (968937719) Revised: 08/2012 Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) Next Interactions Print this page Add to My Med List More about chlorothiazide Side Effects During Pregnancy or Breastfeeding Dosage Information Drug Images Drug Interactions Support Group Pricing & Coupons En Espaรฑol 1 Review Add your own review/rating Drug class: thiazide diuretics Consumer resources Chlorothiazide ... +5 more Professional resources Chlorothiazide (AHFS Monograph) Chlorothiazide Sodium (AHFS Monograph) Chlorothiazide (FDA) Chlorothiazide Injection (FDA) Chlorothiazide (Wolters Kluwer) Other brands: Diuril Related treatment guides Edema High Blood Pressure} FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA WADA Class Anti-Doping Classification Manufacturers Akorn, Inc. Mylan Pharmaceuticals Inc. Sun Pharmaceutical Industries Inc. Fresenius Kabi USA, LLC American Regent, Inc. More... Drug Class Thiazide diuretics Related Drugs thiazide diuretics hydrochlorothiazide , chlorthalidone , metolazone , indapamide , Microzide High Blood Pressure amlodipine , lisinopril , hydrochlorothiazide , furosemide , losartan , metoprolol , atenolol , Lasix , Norvasc , valsartan , More... Edema hydrochlorothiazide , furosemide , Lasix , spironolactone , triamterene , chlorthalidone , torsemide , bumetanide , metolazone , Aldactone , hydrochlorothiazide / triamterene , Maxzide , More... Chlorothiazide Rating 1 User Review 10 /10 1 User Review 10 Rate it! Chlorothiazide Images Chlorothiazide systemic 250 mg (M 50 ) View all images} } little need


a lot of people Diuril Injection no need
sensible New Video Interviews with Elyn Saks, Professor with Schizophrenia it is important

sensible New Video Interviews with Elyn Saks, Professor with Schizophrenia it is important

incredible New Video Interviews with Elyn Saks, Professor with Schizophrenia to combustible
 
Photo :New Video Interviews with Elyn Saks, Professor with Schizophrenia

weighing balance Elyn Saks has become somewhat famous during the past few years because she is one of the few successful career people to come out about their having been diagnosed with schizophrenia while they are still active in their jobs. (Especially where their jobs are not directly related to mental health. Others, like Fred Freese , have been out for many years but they practice psychology where a diagnosis of schizophrenia might arguably be a little more accepted) . She is a tenured Law professor, and associate dean at the University of Southern California. She is also a winner of the Mac Arthur Foundation Fellowship, which she used to create the Saks Institute for Mental Health Law, Policy, and Ethics . She is a great role model for what successful recovery from schizophrenia can look like. Following three new video interviews with Elyn Saks about her experience with schizophrenia. One video is from a recent NARSAD meeting where she presents about Living a Productive Life. She has done a very good TED talk after her book The Center Cannot Hold came out. Her efforts are also spurring other people to come out as covered in this NY Times article Memoir About Schizophrenia Spurs Others to Come Forward The second video is below: A third video, about creativity and mental illness: Here is another good talk at a meeting sponsored by NARSAD / The Brain and Behavior Research Foundation , in which she talks about Living a productive life Here is her TED Talk: Be Sociable, Share this news today! Tweet You might also like Schizophrenia Diagnosis Schizophrenia Education Schizophrenia Video Success Stories Why Tom Insel Ditched the NIMH to Join Google / Alphabet Risk for Schizophrenia May be Identified Through IQ, Memory & Social Intelligence Tests The Importance of Early Treatment for Schizophrenia and Psychosis Brain Signals are Altered in Schizophrenia, May Lead to Biomarker New Report Demonstrates the Cost Effectiveness of Early Treatment you ought to be


asking for New Video Interviews with Elyn Saks, Professor with Schizophrenia per chance
negative What I Learned About People Through Mental Health Screens greatly

negative What I Learned About People Through Mental Health Screens greatly

potential What I Learned About People Through Mental Health Screens you should be
 
Photo :What I Learned About People Through Mental Health Screens

images October 23, 2017 By Madeline Halpern, MHA National Policy and Programs Analyst Before I started working at Mental Health America (MHA), I had almost no experience with mental health screening. My only interaction had been the one time my doctor screened me for depression and then gave me a prescription for antidepressants. Since then, I have come to learn a lot more about mental health, screening, and how early identification can change the trajectory of lives. My job is to look at the 2.25 million mental health screens that have been taken through www.MHAScreening.org and make sense of all those numbers. Every day I see what people are asking, what kind of help they need, and who they are. They re not just numbers to me. They re people. I know that most of our screeners have never heard of us, and just found our screens by Googling, Am I depressed? I know that most of them are young and have never interacted with the mental health system before. I know they re scared, and I know they re looking for help. Although I have learned a lot from going through the data, the most interesting things I ve learned have come from conversations with people I have met face-to-face screening for mental health. One of the most difficult skills to teach humans is empathy. Children don t develop empathy until they are well into their grade school years. So, it can be difficult to explain to people who lack experience with mental health how our screening program works. I often suggest that the person takes a screen related to what they are currently feeling might be problematic in their life. I do this professionally and personally even at parties. Each time I do, I get a little better at understanding how people think about their mental health. One of the most popular screens people take is for anxiety. Most of the time, they take the screen to prove that they re doing well, only to score in the moderate to severe range for anxiety. They ask us what this means, if this is right, and what they can do about that and we re right there to help them. When this happens, I often wonder how many people come to our site thinking they are only a little sad or sometimes moody only to be surprised that they might have depression or bipolar disorder. Our data shows us this is true 68% of screeners report that they ve never been diagnosed with a mental health condition before . By reaching them now, using early identification and prevention strategies, we know we can change lives - before they reach Stage 4 . So many of the warning signs for mental health conditions line up with things we consider to be normal parts of life, like feeling tired all the time, worrying about things, or having trouble sleeping. Most people write these feelings off, rather than thinking they need to talk to someone or take a mental health screen. But there s so much more to their story than that. When someone completes a mental health screen, their results are only the beginning of a longer journey towards wellness. A screen can sometimes uncover a larger issue, or it can be used to start a conversation with family and friends about the importance of caring for your mental health before a crisis. MHA is meeting these screeners where they are at; we are referring them to local Affiliates that can help them navigate mental health in their communities, providing free educational content to learn and share with family and friends to raise awareness about their mental health conditions, and we re protecting access to care and parity for mental health at the local, state, and federal level. I am encouraged by the sheer number of people seeking help, and hope that as I continue to work with the screening data, I will continue to see the real stories behind the numbers. We know at MHA that mental health at any stage should be taken seriously. For those who are starting to experience the first signs of a potential mental illness, we also know that taking an anonymous screen is a great place to start to make sure that the individuals behind the numbers get the help that they need and deserve. Learn more about MHA s online mental health screening program here . Take a free, anonymous, and secure mental health screen by going to www.MHAScreening.org . Tags: Screening screenings mental health Mental Health America Blog common


treatment options What I Learned About People Through Mental Health Screens you got
type of chondrocytes, autologous cultured (Implantation route) good sized

type of chondrocytes, autologous cultured (Implantation route) good sized

mission chondrocytes, autologous cultured (Implantation route) is normally
 
Photo :chondrocytes, autologous cultured (Implantation route)

hind lights chondrocytes, autologous cultured (Implantation route) KON-droe-sites, aw-TALL-oh-gus KUL-cherd Commonly used brand name(s) In the U.S. Carticel Available Dosage Forms: Implant Suspension Therapeutic Class: Musculoskeletal Agent Uses For chondrocytes, autologous cultured Autologous cultured chondrocytes are used, as part of an overall program (that includes knee surgery and special exercises), to help repair damaged knee cartilage caused by acute or repetitive trauma in patients who had not responded to a prior arthroscopic or other surgical repair procedure. Cartilage is a type of tissue that joins together and helps support parts of the body. Autologous cultured chondrocytes are the patient's own cartilage cells. The cells are removed from the patient and sent to a laboratory, where they are processed to increase their number. The cells are then implanted (placed) in the damaged part of the knee. After implantation, the chondrocytes help form new, healthy cartilage. chondrocytes, autologous cultured is to be given only by or under the direct supervision of a trained doctor. Before Using chondrocytes, autologous cultured In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For chondrocytes, autologous cultured, the following should be considered: Allergies Tell your doctor if you have ever had any unusual or allergic reaction to chondrocytes, autologous cultured or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Pediatric Appropriate studies have not been performed on the relationship of age to the effects of Carticel in the pediatric population. Safety and efficacy have not been established. Geriatric Although appropriate studies on the relationship of age to the effects of Carticel have not been performed in the geriatric population, geriatric-specific problems are not expected to limit the usefulness of Carticel in the elderly. Breast Feeding There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Interactions with Medicines Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine. Interactions with Food/Tobacco/Alcohol Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. Other Medical Problems The presence of other medical problems may affect the use of chondrocytes, autologous cultured. Make sure you tell your doctor if you have any other medical problems, especially: Allergy to gentamicin or aminoglycoside antibiotics or Allergy to products made from cow Should not be used in patients with these conditions. Cancer near the injured knee It is not known whether removing and implanting the chondrocyte cells can affect the growth or spread of a nearby cancer. Proper Use of chondrocytes, autologous cultured chondrocytes, autologous cultured is to be given only by a doctor who have completed Vericel's Surgeon Training Program. Carticel will be injected into your knee joint with a needle during surgery. Precautions While Using chondrocytes, autologous cultured Your doctor will check your progress closely while you are receiving chondrocytes, autologous cultured . This will allow your doctor to see if the medicine is working properly and to decide if you should continue to receive it and to check for unwanted effects. Use crutches to help you walk for the first 6 to 8 weeks after receiving the implant. After the implant surgery, your doctor will direct you to start a rehabilitation program that includes exercise. This program is a very important part of your treatment. You will be instructed to start out slowly and to increase gradually the number of times that you do each exercise. To get the most help from this program, it is very important that you follow the instructions as closely as possible. Do not do different exercises, and do not increase the number of times you do each exercise faster than directed . If pain or swelling occurs when you increase the amount of exercise you are doing, go back to the last level of exercise until the pain and swelling are gone, then try again. Use ice packs to help reduce the swelling. Check with your doctor right away if sharp pain occurs in the knee that received the implant, or if locking of the knee occurs. Autologous cultured chondrocytes are the patient's own cartilage cells. Patients undergoing surgical procedures using Carticel are not routinely tested for transmissible infectious diseases and may increase risk to have them. Talk with your doctor about this risk if you are concerned. chondrocytes, autologous cultured Side Effects Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor or nurse immediately if any of the following side effects occur: More common Sharp pain or "locking" when you try to move your knee joint Less common Bruising (severe) difficulty with moving heat, redness, swelling, or oozing at the site of surgery muscle pain or stiffness pain, swelling, or redness in the joints Less common or rare Inability to bend the knee swelling of the knee Rare Fever and pain (occurring together) Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them: More common Crackling sound or pain when moving the knee increased growth of scar over your knee joint stiffness or catching of the knee Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. Print this page The information contained in the Truven Health Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you. The use of the Truven Health products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Truven Health and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, TRUVEN HEALTH MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Truven Health does not assume any responsibility or risk for your use of the Truven Health products. Copyright 2017 Truven Health Analytics, Inc. All Rights Reserved.} Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More Help and Support Looking for answers? Ask a question} } could be


continuously chondrocytes, autologous cultured (Implantation route) appearance
to explode Bactimicina Allergy which in retrospect

to explode Bactimicina Allergy which in retrospect

merely enough Bactimicina Allergy directions
 
Photo :Bactimicina Allergy

further Bactimicina Allergy Generic Name: loratadine Dosage Form: tablet Side Effects Dosage Professional Interactions Pregnancy More Breastfeeding Warnings User Reviews Support Group Q & A BACTIMICINA FOR ALLERGY LORATADINE 10 MG/ANTIHISTAMINE Active ingredient (in each tablet) Loratadine USP, 10mg Purpose Antihistamine Slideshow Flonase: Avoid These Top 9 Mistakes Uses temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose. When using this product do not take more than directed. Taking more than directed may cause drowsiness. If pregnant or breast feeding, ask a health professional before use. Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away. Directions adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor Other information TAMPER EVIDENT; DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING see side panel for lot number and expiration date store between 20 and 25 degrees C (68 and 77 degrees F) protect from excessive moisture Inactive ingredients corn starch, lactose monohydrate, magnesium stearate, pregelatinized starch Questions or Comments? 1-800-858-3889 Package Label Bactimicina Allergy loratadine tablet Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:24286-1549 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Loratadine (Loratadine) Loratadine 10 mg Inactive Ingredients Ingredient Name Strength Starch, Corn Lactose Monohydrate Magnesium Stearate Starch, Pregelatinized Corn Product Characteristics Color white Score no score Shape ROUND (RX526) Size 7mm Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:24286-1549-2 2 TABLET (BLISTER) in 1 BOX Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA076134 10/21/2009 Labeler - DLC Laboratories, Inc. (093351930) Establishment Name Address ID/FEI Operations OHM Pharmaceuticals 051565745 manufacture Establishment Name Address ID/FEI Operations DLC Laboratories, Inc. 093351930 relabel Revised: 10/2009 DLC Laboratories, Inc. Next Interactions Print this page Add to My Med List More about Bactimicina Allergy (loratadine) Side Effects During Pregnancy or Breastfeeding Dosage Information Drug Interactions Support Group 0 Reviews Add your own review/rating Drug class: antihistamines Consumer resources Professional resources Loratadine (AHFS Monograph) Loratadine Tablet (FDA) Other brands: Claritin , Alavert , Allergy Relief Tablets , Allergy Relief 24 Hour , ... +2 more Related treatment guides Allergic Rhinitis Urticaria FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx OTC Availability Rx and/or OTC B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Drug Class Antihistamines Related Drugs antihistamines loratadine , cetirizine , Zyrtec , hydroxyzine , Claritin , promethazine Allergic Rhinitis prednisone , Zyrtec , promethazine , fluticasone nasal , loratadine , cetirizine , Flonase , triamcinolone nasal , montelukast , Claritin , Singulair , More... Urticaria Zyrtec , promethazine , loratadine , cetirizine , Claritin , diphenhydramine , Benadryl , fexofenadine , doxepin , levocetirizine , Allegra , Phenergan , More... Bactimicina Allergy Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! truly fizzling out


a good option Bactimicina Allergy is widely known
every person Aminosyn of what's

every person Aminosyn of what's

health insurance Aminosyn generally
 
Photo :Aminosyn

affordably Aminosyn Generic Name: Amino Acid Injection Solution (a-MEE-noe AS-id in-JEK-shun) Brand Name: Aminosyn, Clinisol SF Overview Side Effects Dosage Professional Interactions More User Reviews Support Group Q & A Uses of Aminosyn: It is used to give nutrition to the body. What do I need to tell my doctor BEFORE I take Aminosyn? If you have an allergy to Aminosyn (amino acid injection solution) or any part of this medicine. If you are allergic to any drugs like this one, any other drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs. If you have any of these health problems: High blood ammonia levels, low blood volume, certain amino acid metabolism problems, or blood acid or electrolyte problems. This is not a list of all drugs or health problems that interact with Aminosyn. Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this medicine with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor. Slideshow Top 11 Reasons Why You Should Get Your Flu Vaccine Now What are some things I need to know or do while I take Aminosyn? Tell all of your health care providers that you take Aminosyn. This includes your doctors, nurses, pharmacists, and dentists. Have blood work checked as you have been told by the doctor. Talk with the doctor. If you are allergic to sulfites, talk with your doctor. Some products have sulfites. If you are 65 or older, use this medicine with care. You could have more side effects. Use with care in children. Talk with the doctor. Use with care in newborns. Talk with the doctor. Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using Aminosyn while you are pregnant. Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby. How is this medicine (Aminosyn) best taken? Use this medicine as ordered by your doctor. Read all information given to you. Follow all instructions closely. It is given as an infusion into a vein over a period of time. What do I do if I miss a dose? Call your doctor to find out what to do. Dosage Information (comprehensive) What are some side effects that I need to call my doctor about right away? WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect: Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat. Signs of fluid and electrolyte problems like mood changes, confusion, muscle pain or weakness, a heartbeat that does not feel normal, very bad dizziness or passing out, fast heartbeat, more thirst, seizures, feeling very tired or weak, not hungry, unable to pass urine or change in the amount of urine produced, dry mouth, dry eyes, or very bad upset stomach or throwing up. Shortness of breath, a big weight gain, or swelling in the arms or legs. What are some other side effects of Aminosyn? All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if you have any side effects that bother you or do not go away. These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects at http://www.fda.gov/medwatch. Side Effects (complete list) If OVERDOSE is suspected: If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened. How do I store and/or throw out Aminosyn? If you need to store Aminosyn at home, talk with your doctor, nurse, or pharmacist about how to store it. Consumer Information Use and Disclaimer If your symptoms or health problems do not get better or if they become worse, call your doctor. Do not share your drugs with others and do not take anyone else's drugs. Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor. Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins. Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets. Check with your pharmacist about how to throw out unused drugs. Some drugs may have another patient information leaflet. Check with your pharmacist. If you have any questions about this medicine, please talk with your doctor, nurse, pharmacist, or other health care provider. If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened. This information should not be used to decide whether or not to take Aminosyn or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this medicine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to Aminosyn. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this medicine. Review Date: November 1, 2017 Next Side Effects Print this page Add to My Med List More about Aminosyn (parenteral nutrition solution) Side Effects Dosage Information Drug Interactions Support Group 0 Reviews Add your own review/rating Drug class: intravenous nutritional products Professional resources Aminosyn (FDA) Other Formulations Aminosyn-HBC Aminosyn-RF Aminosyn-HF Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Aminosyn Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! Manufacturer Pfizer Inc. Drug Class Intravenous nutritional products Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More weakness


all and sundry Aminosyn incidentally
bring together Aminosalicylic Acid thinking of

bring together Aminosalicylic Acid thinking of

prospective customers Aminosalicylic Acid of goods
 
Photo :Aminosalicylic Acid

sensible [15:40 kg and Adolescents 15 years: Refer to adult dosing. Dosing: Renal Impairment Manufacturer's labeling: There are no dosage adjustments provided in the manufacturer's labeling; contraindicated in severe impairment Alternate dosing: Aronoff 2007: Note: Dosage adjustments are based on a usual dose of 50 mg/kg/dose every 8 hours GFR >50 mL/minute: No dosage adjustment necessary GFR 10 to 50 mL/minute: Administer 50% to 75% of usual dose GFR] Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Aminosalicylic acid Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! Drug Class Aminosalicylates Related Drugs aminosalicylates Paser Tuberculosis, Resistant bedaquiline , Paser , More... Tuberculosis, Active ciprofloxacin , Levaquin , levofloxacin , rifampin , moxifloxacin , Avelox , isoniazid , ethambutol , amikacin , gatifloxacin , More... future years


appropriate Aminosalicylic Acid legitimate
don't forget Ask the Doc - Q & A that offer

don't forget Ask the Doc - Q & A that offer

could be Ask the Doc - Q & A individual that
 
Photo :Ask the Doc - Q & A

a good option About Our Expert: Dr. James W. Brann, M.D., is a retired OB/GYN and editorial director of Women's Healthcare Topics. Do you have questions about trying to conceive, pregnancy, or giving birth? Ask the doc any question you have, and you'll get easy to understand answers without all the medical jargon that might confuse you! Submit a QUESTION below! NOTE: I do apologize, you will have to signup and verify your email address inorder to comment in the pregnancy discussions. All posts will be moderated before going live. Doc Please enable JavaScript to view the comments powered by Disqus. shots


conventional Ask the Doc - Q & A you truly
were you aware Diuril Sodium (Intravenous) out of the blue

were you aware Diuril Sodium (Intravenous) out of the blue

is amazingly Diuril Sodium (Intravenous) most valuable
 
Photo :Diuril Sodium (Intravenous)

maintain Diuril Sodium (Intravenous) Generic Name: chlorothiazide (Intravenous route) klor-oh-THYE-a-zide Overview Side Effects Dosage Interactions Pregnancy More Breastfeeding Warnings User Reviews Support Group Q & A Pricing & Coupons Commonly used brand name(s) In the U.S. Diuril Sodium Sodium Diuril Available Dosage Forms: Powder for Solution Therapeutic Class: Cardiovascular Agent Pharmacologic Class: Diuretic Chemical Class: Thiazide Slideshow Love Your Dad? Here's 10 Heart-Healthy Gifts For Father's Day Uses For Diuril Sodium Chlorothiazide is used to treat fluid retention (edema) that is caused by congestive heart failure, severe liver disease (cirrhosis), kidney disease, or from treatment with a steroid or hormone medicine. Chlorothiazide is a thiazide diuretic. It reduces the amount of water in the body by increasing the flow of urine, which helps reduce fluid retention (edema). This medicine is available only with your doctor's prescription. Before Using Diuril Sodium In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: Allergies Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Pediatric Appropriate studies have not been performed on the relationship of age to the effects of chlorothiazide in the pediatric population. Safety and efficacy have not been established. Geriatric Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of chlorothiazide in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require an adjustment in the dose for patients receiving chlorothiazide. Pregnancy Pregnancy Category Explanation All Trimesters C Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. Breast Feeding Studies suggest that this medication may alter milk production or composition. If an alternative to this medication is not prescribed, you should monitor the infant for side effects and adequate milk intake. Interactions with Medicines Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Aceclofenac Acemetacin Acetyldigoxin Amphetamine Amtolmetin Guacil Arsenic Trioxide Aspirin Benzphetamine Bepridil Bromfenac Bufexamac Celecoxib Choline Salicylate Clonixin Deslanoside Dexibuprofen Dexketoprofen Dextroamphetamine Diclofenac Diflunisal Digitalis Digitoxin Digoxin Dipyrone Dofetilide Droxicam Etodolac Etofenamate Etoricoxib Felbinac Fenoprofen Fepradinol Feprazone Flecainide Floctafenine Flufenamic Acid Flurbiprofen Ibuprofen Indomethacin Ketanserin Ketoprofen Ketorolac Lisdexamfetamine Lithium Lornoxicam Loxoprofen Lumiracoxib Meclofenamate Mefenamic Acid Meloxicam Methamphetamine Metildigoxin Morniflumate Nabumetone Naproxen Nepafenac Niflumic Acid Nimesulide Nimesulide Beta Cyclodextrin Oxaprozin Oxyphenbutazone Parecoxib Phenylbutazone Piketoprofen Piroxicam Proglumetacin Propyphenazone Proquazone Rofecoxib Salicylic Acid Salsalate Sodium Salicylate Sulindac Tenoxicam Tiaprofenic Acid Tolfenamic Acid Tolmetin Valdecoxib Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Aminolevulinic Acid Calcium Ginkgo Gossypol Licorice Interactions with Food/Tobacco/Alcohol Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. Other Medical Problems The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially: Anuria (not able to form urine) Should not be used in patients with this condition. Asthma or Diabetes or Gout or Hypercalcemia (high calcium in the blood) or Hyperuricemia (high uric acid in the blood) or Hypochloremia (low chloride in the blood) or Hypokalemia (low potassium in the blood) or Hypomagnesemia (low magnesium in the blood) or Hyponatremia (low sodium in the blood) or Hypophosphatemia (low phosphorus in the blood) or Liver disease or Systemic lupus erythematosus Use with caution. This medicine may make these conditions worse. Kidney disease Use with caution. The effects of the medicine may be increased because of slower removal of the medicine from the body. Proper Use of chlorothiazide This section provides information on the proper use of a number of products that contain chlorothiazide. It may not be specific to Diuril Sodium. Please read with care. A nurse or other trained health professional will give you this medicine. This medicine is given through a needle placed in one of your veins. Precautions While Using Diuril Sodium Your doctor will only give you a few doses of this medicine until your condition improves, and then you will be switched to an oral medicine that works the same way. If you have any concerns about this, talk to your doctor. Diuril Sodium Side Effects Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor or nurse immediately if any of the following side effects occur: Incidence not known Abdominal or stomach pain back, leg, or stomach pains black, tarry stools bleeding gums blisters on skin blood in urine or stools bloody or cloudy urine blue lips and fingernails blurred vision burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings chest pain chills clay-colored stools cold sweats confusion constipation cough or hoarseness coughing that sometimes produces a pink frothy sputum coughing up blood darkened urine decrease in urine output or decrease in urine-concentrating ability decreased frequency or amount of urine diarrhea difficult, fast, or noisy breathing, sometimes with wheezing difficulty swallowing dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly dry mouth fast heartbeat feeling of constant movement of self or surroundings fever flushed, dry skin fruit-like breath odor general feeling of discomfort or illness general feeling of tiredness or weakness headache hives increased blood pressure increased hunger increased sensitivity of skin to sunlight increased sweating increased thirst increased urination indigestion itching joint pain, stiffness, or swelling loss of appetite lower back or side pain muscle cramps or pain nausea nosebleeds numbness, tingling, pain, or weakness in hands or feet pain in joints or muscles painful or difficult urination pains in stomach, side, or abdomen, possibly radiating to the back pale skin pinpoint red spots on skin puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue redness or other discoloration of skin redness, soreness, or itching skin seizures sensation of spinning severe sunburn shortness of breath skin rash sores, ulcers, or white spots on lips or in mouth sores, welting, or blisters sugar in the urine sweating swelling in legs and ankles swelling of face, fingers, or lower legs swollen or painful glands tenderness of salivary glands thickening of bronchial secretions tightness in chest trembling troubled breathing unexplained weight loss unpleasant breath odor unusual bleeding or bruising unusual tiredness or weakness unusual weight loss vomiting of blood weight gain yellow eyes or skin Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them: Incidence not known Blistering, peeling, or loosening of skin cracks in the skin cramping decreased interest in sexual intercourse difficulty having a bowel movement (stool) hair loss, thinning of hair inability to have or keep an erection loss in sexual ability, desire, drive, or performance loss of heat from the body muscle spasm pinpoint red or purple spots on skin red, irritated eyes red, swollen skin restlessness scaly skin weakness Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. Side Effects (complete list) The information contained in the Truven Health Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you. The use of the Truven Health products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Truven Health and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, TRUVEN HEALTH MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Truven Health does not assume any responsibility or risk for your use of the Truven Health products. Copyright 2017 Truven Health Analytics, Inc. All Rights Reserved. Next Side Effects Print this page Add to My Med List More about Diuril Sodium (chlorothiazide) Side Effects During Pregnancy or Breastfeeding Dosage Information Drug Interactions Support Group Pricing & Coupons 0 Reviews Add your own review/rating Drug class: thiazide diuretics Consumer resources Sodium Diuril (Advanced Reading) Professional resources Chlorothiazide Sodium (AHFS Monograph) Chlorothiazide Injection (FDA) Other Formulations Diuril Related treatment guides Edema High Blood Pressure} Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug WADA Class Anti-Doping Classification Manufacturers Akorn, Inc. Oak Pharmaceuticals, Inc ( subsidiary of Akorn, Inc) Drug Class Thiazide diuretics Related Drugs High Blood Pressure amlodipine , lisinopril , hydrochlorothiazide , furosemide , losartan , metoprolol , atenolol , Lasix , Norvasc , valsartan , More... Edema hydrochlorothiazide , furosemide , Lasix , spironolactone , triamterene , chlorthalidone , torsemide , bumetanide , metolazone , Aldactone , hydrochlorothiazide / triamterene , Maxzide , More... Diuril Sodium Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! Help and Support Looking for answers? Ask a question or go join the Diuril Sodium support group to connect with others who have similar interests.} } is amazingly


keen about Diuril Sodium (Intravenous) aimed at
the roles Schizophrenia   A Recovery Story (video) family member

the roles Schizophrenia A Recovery Story (video) family member

all of sudden Schizophrenia A Recovery Story (video) getting old
 
Photo :Schizophrenia A Recovery Story (video)

positively This is a good self-documentary by a 26 year old in England named Johnny Benjamin, about his own recovery process. Since he s been on the road to recovery he s become a real advocate for change in the mental health community and has been very active in social media. He has also gone through the cycle of challenges (like depression) that are common in schizophrenia but he has now gotten on a treatment program (that he describes in the video) that is working well for him and doing well in life. You can learn more about Johnny Benjamin and his activities at the following links: His Blog is here: https://www.time-to-change.org.uk/blog/35909 His Twitter Feed here: https://twitter.com/MrJonnyBenjamin2 His Youtube Channel: https://www.youtube.com/user/johnjusthuman Be Sociable, Share this news today! Tweet You might also like Schizophrenia Video Success Stories Voices A New Documentary on the Untold Stories of Schizophrenia The SunnyBoy (A Good, New Documentary Movie on Schizophrenia) The Importance of Early Treatment for Schizophrenia and Psychosis New Video Interviews with Elyn Saks, Professor with Schizophrenia A Good Intro to Schizophrenia Recovery (video) Schizophrenia Biology Lecture by Stanford Neuroscience Professor most useful


committed Schizophrenia A Recovery Story (video) train
day off 4 Tips to Make the Grade in Mental Health recommend

day off 4 Tips to Make the Grade in Mental Health recommend

political views 4 Tips to Make the Grade in Mental Health on occasion
 
Photo :4 Tips to Make the Grade in Mental Health

everything October 30, 2017 By Shannon Hazlitt Harts, Social Media Specialist, bp and esperanza Magazines During the fall, many feel a familiar charge of energy as the leaves take on fiery colors and the temperatures cool off. However, for college students, the season s progression can take on another meaning. As the leaves and temperatures drop, so fades the excitement of the start of the semester. In this void, the stresses of midterms, relationship issues and loneliness can come creeping in. Stress can take hold at any time for college students, and anxiety is a rising concern . This and other volatile emotions can lead to the life-changing diagnosis of a mental health condition. Luckily, there are ways colleges are stepping up to help students (some involving furry friends), and there are ways students grappling with their mental wellness can find support. Mental illness is prevalent among young adults. The way the adolescent brain develops and the way teenagers behave make the late-teen years a logical time for mental health conditions to manifest, according to bp Magazine . Bipolar disorder, in particular, can become apparent in a person s late teen or early adult years . What revs up the onset of bipolar disorder are some common behaviors for college students. These include adapting unhealthy sleep schedules and using substances such as alcohol and marijuana. Recent reports have revealed college counselors are seeing a record number of students dealing with mental health issues. As many as 48 percent of college students have had counseling for concerns with their mental wellness. The good news: colleges are reacting. Universities and colleges are investing more in mental health and developing rapid response programs for students in crisis . Universities are even investing in unconventional strategies during high-stress times, such as providing trained therapy dogs on campus for exam season. Students are also discovering more ways to get help. Here is some advice college students with bipolar disorder shared with bp Magazine on tackling college life: Break assignments into smaller components: "Put your attention on the task at hand." Allie Ask for special accommodations by going to a college or university s disability office: " Know your rights academically . Go to your college s disability office and try to get a good advocate. Be strong in pushing for what you are entitled to under law (Americans With Disabilities Act, Section 504, or Canadian human rights legislation) Consider what you want to disclose to professors. If the school sends letters to the professors about disability accommodations, find out whether yours is mentioned." Mark Find an outlet for self-expression: " Writing, art, music anything that helps work through your emotions and feelings. " -Allie Seek peer support : "It s one thing to get a bunch of ideas and strategies from advisors. But people who have been at your school are going to know what it s like to go through it, maybe even have ideas about how to deal with some of the professors." Mark While the stress of college can seem overwhelming, especially if you are also coping with a mental health condition such as bipolar disorder, it s important to remember you are not alone. Even the late Carrie Fisher grappled with her mental health. She had bipolar disorder, and was instrumental in starting bp Magazine. I ll leave you with some of her inspiring words: I ve had to rise to occasions not just on the stage in order to survive, so that bruising is my blessing and those liabilities are my strength now. May the force of mental wellness be with you, whether you are taking on challenges in the collegiate realm or in everyday life! Shannon Hazlitt Harts is a Social Media Specialist for bp and esperanza Magazines. She helps manage bp Magazine and award-winning bpHope blog and coordinates bp and esperanza Magazines. bp Magazine for bipolar disorder and esperanza Magazine for anxiety and depression feature inspirational first-person profiles combined with educational resources and the latest news and research to help readers build healthier lifestyles as well as mental wellness. Shannon also helps oversee bp and esperanza s online hubs, bpHope.com and HopeToCope.com , where you can find resources to increase awareness of bipolar disorder, anxiety and depression, including profiles from celebrities such as Demi Lovato , Kristen Bell , Howie Mandel , and Mary Lambert . You can follow bp Magazine on Facebook here and esperanza on Facebook here . Shannon graduated from Syracuse University in December 2014 and previously worked at a television news station as well as a newspaper. You can follow her on Twitter @ShanHazlitt. If you are a college student with tips for mental wellness, feel free to pass them along to Shannon at social@bphope.com . Tags: back to school life on campus school tips college Mental Health America Blog regular


profiting from 4 Tips to Make the Grade in Mental Health to make use of
training exercise Cholografin Meglumine kit

training exercise Cholografin Meglumine kit

right away Cholografin Meglumine you may get
 
Photo :Cholografin Meglumine

track Cholografin Meglumine Generic Name: Iodipamide Meglumine Dosage Form: injection, solution Overview Side Effects Dosage Professional Interactions More Breastfeeding Warnings User Reviews Support Group Q & A CHOLOGRAFIN MEGLUMINE Iodipamide Meglumine Injection USP 52% NOT FOR INTRATHECAL USE FOR INTRAVENOUS USE ONLY Slideshow Hives: The What, Where, And Why Of This Bizarre Skin Condition Cholografin Meglumine Description Cholografin Meglumine (lodipamide Meglumine Injection 52%) is a radiopaque contrast agent for rapid intravenous cholangiography and cholecystography supplied as a sterile, aqueous solution. Each mL provides 520 mg iodipamide meglumine; at manufacture, 3.2 mg sodium citrate buffer and 0.4 mg edetate disodium sequestering agent are added per mL. The pH has been adjusted between 6.5 and 7.7 with meglumine and iodipamide. Each mL of solution also contains approximately 0.91 mg (0.039 mEq) sodium [18.2 mg/20 mL] and 257 mg organically bound iodine (5.2 g/20 mL). At the time of manufacture, the air in the container is replaced by nitrogen. The appearance of the solution may vary from essentially colorless to light amber. Solutions which have become substantially darker, however, should not be used. Cholografin Meglumine - Clinical Pharmacology Following intravenous administration of Cholografin Meglumine, iodipamide is carried to the liver where it is rapidly secreted. The contrast medium appears in the bile within 10 to 15 minutes after injection, thus permitting visualization of the hepatic and common bile ducts, even in cholecystectomized patients. The biliary ducts are readily visualized within about 25 minutes after administration, except in patients with impaired liver function. The gallbladder begins to fill within an hour after injection; maximum filling is reached after two to two and one-half hours. The contrast medium is finally eliminated in the feces without passing through the enterohepatic circulation, except for approximately 10 percent of the intravenously administered dose which is excreted through the kidneys. The LD 50 for intravenous administration of a 52% iodipamide meglumine solution in mice is 6.2 0.3 mL/kg (equivalent to 3224 156 mg iodipamide meglumine/kg). Indications and Usage for Cholografin Meglumine Cholografin Meglumine is indicated for intravenous cholangiography and cholecystography as follows: (a) visualization of the gallbladder and biliary ducts in the differential diagnosis of acute abdominal conditions, (b) visualization of the biliary ducts, especially in patients with symptoms after cholecystectomy, and (c) visualization of the gallbladder in patients unable to take oral contrast media or to absorb contrast media from the gastrointestinal tract. Contraindications Cholografin is contraindicated for use in intrathecal procedures. lodipamide meglumine is contraindicated in patients with a hypersensitivity to salts of iodipamide or who exhibit sensitivity reactions to the test dose. It is also contraindicated in patients with concomitant severe impairment of renal and liver function. Warnings Severe Adverse Events Inadvertent Intrathecal Administration Serious adverse reactions have been reported due to the inadvertent intrathecal administration of iodinated contrast media that are not indicated for intrathecal use. These serious adverse reactions include: death,convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. Special attention must be given to insure that this drug product is not inadvertently administered intrathecally. The possibility exists for inadvertent administration into the intrathecal space during epidural administrations. Therefore, epidural administration procedures, such as pain management catheter placement, should not be performed with use of this product. General Administration of radiopaque materials to patients known or suspected to have pheochromocytoma should be performed with extreme caution. If, in the opinion of the physician, the possible benefits of such procedures outweigh the considered risks, the procedures may be performed; however, the amount of radiopaque medium injected should be kept to an absolute minimum. The blood pressure should be assessed throughout the procedure and measures for treatment of a hypertensive crisis should be available. Contrast media have been shown to promote the phenomenon of sickling in individuals who are homozygous for sickle cell disease when the material is injected intravenously or intra-arterially. Since iodine-containing contrast agents may alter the results of thyroid function tests, such tests, if indicated, should be performed prior to the administration of this preparation. A history of sensitivity to iodine per se or to other contrast agents is not an absolute contraindication to the use of iodipamide meglumine, but calls for extreme caution in administration. Precautions Diagnostic procedures which involve the use of radiopaque contrast agents should be carried out under the direction of personnel with the prerequisite training and with a thorough knowledge of the particular procedure to be performed. Appropriate facilities should be available for coping with situations which may arise as a result of the procedure, as well as for emergency treatment of severe reactions to the contrast agent itself. After intravascular administration of a radiopaque agent, competent personnel and emergency facilities should be available for at least 30 to 60 minutes, since severe delayed reactions have been known to occur. These severe, life-threatening reactions suggest hypersensitivity to the radiopaque agent, which has prompted the use of several pretesting methods, none of which can be relied upon to predict severe reactions. Many authorities question the value of any pretest. A history of bronchial asthma or allergy, a family history of allergy, or a previous reaction to a contrast agent warrant special attention. Such a history, by suggesting histamine sensitivity and a consequent proneness to reactions, may be more accurate than pretesting in predicting the likelihood of a reaction, although not necessarily the severity or type of reaction in the individual case. The sensitivity test most often performed is the slow injection of 0.5 to 1.0 mL of the radiopaque medium, administered intravenously, prior to injection of the full diagnostic dose. It should be noted that the absence of a reaction to the test dose does not preclude the possibility of a reaction to the full diagnostic dose. If the test dose causes an untoward response of any kind, the necessity for continuing with the examination should be carefully reevaluated and, if it is deemed essential, the examination should be conducted with all possible caution. In rare instances reactions to the test dose itself may be extremely severe; therefore, close observation of the patient, and facilities for emergency treatment, appear indicated. Caution should be exercised with the use of radiopaque media in severely debilitated patients and in those with marked hypertension. The possibility of thrombosis should be borne in mind when intravenous techniques are employed. Contrast agents may interfere with some chemical determinations made on urine specimens; therefore, urine should be collected before administration of the contrast media or two or more days afterwards. Some clinicians feel it may be advisable to have a continuous intravenous infusion running prior to and during administration of the drug. The admixture of Benadryl (Diphenhydramine Hydrochloride Injection) with Cholografin Meglumine (lodipamide Meglumine Injection USP 52%) may cause a precipitate which may form in the syringe or tubing. If antihistamines are administered concomitantly, they should not be mixed with the contrast agent but administered at another site. Usage in Pregnancy The safety of iodipamide meglumine for use during pregnancy has not been established; therefore, it should be used in pregnant patients, only when, in the judgment of the physician, its use is deemed essential to the welfare of the patient. Adverse Reactions Local reactions at the site of injection are not observed, unless excessive amounts are extravasated during injection. After too rapid administration, mild transient symptoms such as restlessness, sensations of warmth, sneezing, perspiration, salivation, flushing, pressure in the upper abdomen, dizziness, nausea, vomiting, chills, fever, headache, pallor and tremors may occur. These symptoms disappear when the injection has been completed. Rarely, swollen eyelids, laryngospasm, respiratory difficulties, hypotension, cardiac reactions and cyanosis have been reported. Hypersensitivity reactions may occur. In rare instances, despite the most careful sensitivity testing, anaphylactoid reactions may occur. Renal function tests may be altered and renal failure may occur. Cholografin Meglumine Dosage and Administration Cholografin Meglumine (lodipamide Meglumine Injection USP 52%) is for intravenous use only. Directions For Use Preparation of the Patient: For best results, the usual preliminary measures for cholecystography are recommended, particularly in cholecystectomized patients, i.e., a low residue diet on the day before examination and administration of castor oil the night before or neostigmine at the time of examination to dispel excess intestinal gas. Cholecystography is preferably carried out in the morning with the patient fasting. Dose: The usual adult dose is 20 mL. For infants and children, the suggested dose is 0.3 to 0.6 mL/kg of body weight; the dosage for infants and children should not exceed 20 mL. Note: The dose should not be repeated for 24 hours. Administration: After warming to body temperature, Cholografin Meglumine should be given by slow intravenous injection, following the usual precautions of intravenous administration. It is important that the preparation be injected slowly over a period of 10 minutes. Use of a narrow bore hypodermic needle will ensure a slow rate of injection. During the injection, the patient should be watched for untoward reactions such as a feeling of warmth, flushing and occasionally nausea. Nausea indicates that the injection rate is too rapid. Radiography: A scout film should be exposed routinely before the intravenous injection is made. Position of the Patient: With the patient prone and the right side elevated, radiographs are made in the posterior-anterior projection. Some radiologists prefer the supine position with the left side elevated. Serial 10-minute exposures should be started 10 minutes after the injection is made and continued until optimal visualization of the biliary ducts is obtained. Wet films should be examined immediately by the radiologist. In some cases a 15-degree rotation or the upright position may prove helpful. Depending on the situation revealed by the roentgenograms in which the duct is first seen, the position of the subject should be changed to displace the shadow of the common bile duct from that of the spine. Tomography is a useful technique for enhancing bile duct visualization after administration of the radiopaque medium. Examination of the gallbladder should be started about two hours after administration. The standard positions in routine examination of the gallbladder should be used unless otherwise indicated. There is no need for the patient to remain quiet awaiting the time for the gallbladder film to be exposed. Moderate activity on the part of the patient will, in most cases, preclude stratification of the contrast agent in the gallbladder. If the contrast medium should stratify in the gallbladder, decubitus as well as upright films should be obtained. Additional exposures may be made after the ingestion of a fatty meal. If visualization is not achieved after two and one-half hours, the patient should be returned for a 24-hour film, whenever possible. Occasionally, delayed opacification of the gallbladder will occur in 24 hours. In infants and children, gallbladder visualization may be expected to occur 30 minutes to four hours after administration. Note: In the presence of liver disease (BSP retention greater than 30 to 40 percent), the contrast medium is not excreted efficiently by the liver and visualization is usually not achieved. Visualization is rarely achieved in the presence of a serum bilirubin of 3.0 mg per 100 mL if the elevated bilirubin level is due to mechanical obstruction or hepatocellular damage. In the presence of severe liver damage, the contrast agent is excreted by the kidneys. Interpretation: When intravenous cholecystography and cholangiography are used as an aid in the differential diagnosis of acute abdominal conditions, visualization of the gallbladder is considered strong evidence against a diagnosis of acute cholecystitis, while nonvisualization of the gallbladder two and one-half hours after administration with visualization of the bile ducts is considered strong evidence in favor of a diagnosis of acute cholecystitis (if the bile ducts are only faintly visualized, gallbladder films four hours after administration may occasionally show visualization of the gallbladder). When neither the bile ducts nor the gallbladder is visualized, the study provides no definitive information with regard to determining the presence or absence of acute cholecystitis. How is Cholografin Meglumine Supplied Cholografin Meglumine (lodipamide Meglumine Injection USP 52%) is available in single dose vials of 20 mL (NDC 0270-0265-20). Storage Protect from light; store at 20 25 C (68 77 F) [See USP]; avoid excessive heat. In the event that crystallization occurs, the solution may be clarified by placing the vial in hot water and shaking gently for several minutes or until the solids redissolve. If cloudiness persists, discard the preparation. Allow the solution to cool to body temperature before administering. Manufactured for Bracco Diagnostics Inc. Monroe Township, NJ 08831 by Patheon Italia S.p.A. 03013 Ferentino (Italy) Revised October 2013 CL64901 255763 Cholografin Meglumine Iodipamide Meglumine Cholografin Meglumine iodipamide meglumine injection, solution Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0270-0265 Route of Administration INTRAVENOUS DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Iodipamide meglumine (iodipamide) Iodipamide meglumine 520 mg in 1 mL Inactive Ingredients Ingredient Name Strength edetate disodium 0.4 mg in 1 mL sodium citrate 3.2 mg in 1 mL Packaging # Item Code Package Description 1 NDC:0270-0265-20 10 VIAL in 1 PACKAGE 1 20 mL in 1 VIAL Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA009321 07/09/1955 Labeler - BRACCO DIAGNOSTICS INC (849234661) Registrant - BRACCO DIAGNOSTICS INC (849234661) Establishment Name Address ID/FEI Operations Patheon Italia S.p.A 434078638 ANALYSIS(0270-0265), MANUFACTURE(0270-0265) Establishment Name Address ID/FEI Operations Justesa Imagen, S.A.U 477020325 API MANUFACTURE(0270-0265) Establishment Name Address ID/FEI Operations Interpharma Praha, a.s 644354706 API MANUFACTURE(0270-0265) Revised: 12/2014 BRACCO DIAGNOSTICS INC Next Interactions Print this page Add to My Med List More about Cholografin Meglumine (iodipamide) Side Effects Breastfeeding Dosage Information Drug Interactions Support Group 0 Reviews Add your own review/rating Drug class: ionic iodinated contrast media Consumer resources Cholografin Meglumine} FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Drug Class Ionic iodinated contrast media Related Drugs ionic iodinated contrast media Gastrografin , diatrizoate , Hexabrix , Cysto-Conray II , Hypaque Cholografin Meglumine Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first!} } realize


weighing balance Cholografin Meglumine regular
circle of relatives Bactocill standard

circle of relatives Bactocill standard

might Bactocill all of the sudden
 
Photo :Bactocill

grow to be Bactocill Generic Name: penicillin (Oral route, Injection route, Intravenous route, Intramuscular route) Overview Side Effects Dosage Professional Interactions More Pregnancy Warnings User Reviews Drug Images Support Group Q & A Compare Alternatives Pricing & Coupons Commonly used brand name(s) In the U.S. Amoxil Bactocill Bicillin L-A Cloxapen Crysticillin Dynapen Geocillin Nafcil Pfizerpen Pipracil Principen Staphcillin Ticar Veetids In Canada Amoxil Pediatric Ampicillin Sodium Apo-Amoxi Apo-Amoxi Sugar-Free Apo-Cloxi Apo-Pen-Vk Gen-Amoxicillin Med Amoxicillin Nadopen V 200 Nadopen V 400 Novamoxin Available Dosage Forms: Tablet Powder for Suspension Capsule Powder for Solution Suspension Solution Tablet, Chewable Tablet for Suspension Tablet, Extended Release Syrup Slideshow Sore Throat Remedies And Treatments Uses For Bactocill Penicillins are used to treat infections caused by bacteria. They work by killing the bacteria or preventing their growth. There are several different kinds of penicillins. Each is used to treat different kinds of infections. One kind of penicillin usually may not be used in place of another. In addition, penicillins are used to treat bacterial infections in many different parts of the body. They are sometimes given with other antibacterial medicines (antibiotics). Some of the penicillins may also be used for other problems as determined by your doctor. However, none of the penicillins will work for colds, flu, or other virus infections. Penicillins are available only with your doctor's prescription. Before Using Bactocill Allergies Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Pediatric Many penicillins have been used in children and, in effective doses, are not expected to cause different side effects or problems in children than they do in adults. Some strengths of the chewable tablets of amoxicillin contain aspartame, which is changed by the body to phenylalanine, a substance that is harmful to patients with phenylketonuria. Geriatric Penicillins have been used in the elderly and have not been shown to cause different side effects or problems in older people than they do in younger adults. Pregnancy Penicillins have not been studied in pregnant women. However, penicillins have been widely used in pregnant women and have not been shown to cause birth defects or other problems in animal studies. Breast Feeding Penicillins pass into the breast milk. Even though only small amounts may pass into breast milk, allergic reactions, diarrhea, fungus infections, and skin rash may occur in nursing babies. Interactions with Medicines Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking any of these medicines, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Using medicines in this class with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Axitinib Bupropion Chlortetracycline Cholera Vaccine, Live Clarithromycin Cyclosporine Daclatasvir Darunavir Deflazacort Demeclocycline Donepezil Doxorubicin Doxorubicin Hydrochloride Liposome Doxycycline Elbasvir Etonogestrel Grazoprevir Lymecycline Meclocycline Methacycline Methotrexate Minocycline Nifedipine Olaparib Oxytetracycline Piperaquine Rolitetracycline Simeprevir Tetracycline Vancomycin Vecuronium Velpatasvir Venetoclax Venlafaxine Warfarin Interactions with Food/Tobacco/Alcohol Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. Other Medical Problems The presence of other medical problems may affect the use of medicines in this class. Make sure you tell your doctor if you have any other medical problems, especially: Allergy, general (such as asthma, eczema, hay fever, hives), history of Patients with a history of general allergies may be more likely to have a severe reaction to penicillins Bleeding problems, history of Patients with a history of bleeding problems may be more likely to have bleeding when receiving carbenicillin, piperacillin, or ticarcillin Congestive heart failure (CHF) or High blood pressure Large doses of carbenicillin or ticarcillin may make these conditions worse, because these medicines contain a large amount of salt Cystic fibrosis Patients with cystic fibrosis may have an increased chance of fever and skin rash when receiving piperacillin Kidney disease Patients with kidney disease may have an increased chance of side effects Mononucleosis ( mono ) Patients with mononucleosis may have an increased chance of skin rash when receiving ampicillin, bacampicillin, or pivampicillin Phenylketonuria Some strengths of the amoxicillin chewable tablets contain aspartame, which is changed by the body to phenylalanine, a substance that is harmful to patients with phenylketonuria. Stomach or intestinal disease, history of (especially colitis, including colitis caused by antibiotics) Patients with a history of stomach or intestinal disease may be more likely to develop colitis while taking penicillins Proper Use of penicillin This section provides information on the proper use of a number of products that contain penicillin. It may not be specific to Bactocill. Please read with care. Penicillins (except bacampicillin tablets, amoxicillin, penicillin V, pivampicillin, and pivmecillinam) are best taken with a full glass (8 ounces) of water on an empty stomach (either 1 hour before or 2 hours after meals) unless otherwise directed by your doctor. For patients taking amoxicillin, penicillin V, pivampicillin, and pivmecillinam: Amoxicillin, penicillin V, pivampicillin, and pivmecillinam may be taken on a full or empty stomach. The liquid form of amoxicillin may also be taken by itself or mixed with formulas, milk, fruit juice, water, ginger ale, or other cold drinks. If mixed with other liquids, take immediately after mixing. Be sure to drink all the liquid to get the full dose of medicine. For patients taking bacampicillin: The liquid form of this medicine is best taken with a full glass (8 ounces) of water on an empty stomach (either 1 hour before or 2 hours after meals) unless otherwise directed by your doctor. The tablet form of this medicine may be taken on a full or empty stomach. For patients taking penicillin G by mouth: Do not drink acidic fruit juices (for example, orange or grapefruit juice) or other acidic beverages within 1 hour of taking penicillin G since this may keep the medicine from working properly. For patients taking the oral liquid form of penicillins: This medicine is to be taken by mouth even if it comes in a dropper bottle. If this medicine does not come in a dropper bottle, use a specially marked measuring spoon or other device to measure each dose accurately. The average household teaspoon may not hold the right amount of liquid. Do not use after the expiration date on the label. The medicine may not work properly after that date. If you have any questions about this, check with your pharmacist. For patients taking the chewable tablet form of amoxicillin: Tablets should be chewed or crushed before they are swallowed. To help clear up your infection completely, keep taking this medicine for the full time of treatment, even if you begin to feel better after a few days. If you have a strep infection, you should keep taking this medicine for at least 10 days. This is especially important in strep infections. Serious heart problems could develop later if your infection is not cleared up completely. Also, if you stop taking this medicine too soon, your symptoms may return. This medicine works best when there is a constant amount in the blood or urine. To help keep the amount constant, do not miss any doses. Also, it is best to take the doses at evenly spaced times, day and night . For example, if you are to take four doses a day, the doses should be spaced about 6 hours apart. If this interferes with your sleep or other daily activities, or if you need help in planning the best times to take your medicine, check with your health care professional. Make certain your health care professional knows if you are on a low-sodium (low-salt) diet. Some of these medicines contain enough sodium to cause problems in some people. Dosing The dose medicines in this class will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of these medicines. If your dose is different, do not change it unless your doctor tells you to do so. The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine. The number of tablets or teaspoonfuls of suspension that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are taking a penicillin. For amoxicillin: For bacterial infections: For oral dosage forms (capsules, oral suspension, tablets, and chewable tablets): Adults, teenagers, and children weighing more than 40 kilograms (kg) (88 pounds) 250 to 500 milligrams (mg) every eight hours or 500 to 875 mg every twelve hours, depending on the type and severity of the infection. Neonates and infants up to 3 months of age Dose is based on body weight and must be determined by your doctor. The usual dose is 15 mg per kg (6.8 mg per pound) of body weight or less every twelve hours. Infants 3 months of age and older and children weighing up to 40 kg (88 lbs.) Dose is based on body weight and must be determined by your doctor. The usual dose is 6.7 to 13.3 mg per kg (3 to 6 mg per pound) of body weight every eight hours or 12.5 to 22.5 mg per kg (5.7 to 10.2 mg per pound) of body weight every twelve hours. For duodenal ulcers (associated with Helicobacter pylori bacterial infection): For oral dosage forms (capsules, oral suspension, tablets, and chewable tablets): Adults: 1000 mg twice a day every twelve hours for fourteen days, along with the two other medicines, clarithromycin and lansoprazole, as directed by your doctor. Teenagers and children: Use and dose must be determined by your doctor. For dual medicine therapy Adults: 1000 mg three times a day every eight hours for fourteen days, along with the other medicine, lansoprazole, as directed by your doctor. Teenagers and children: Use and dose must be determined by your doctor. For ampicillin: For bacterial infections: For oral dosage forms (capsules and oral suspension): Adults, teenagers, and children weighing more than 20 kilograms (kg) (44 pounds) 250 to 500 milligrams (mg) every six hours. Infants and children weighing up to 20 kg (44 pounds) Dose is based on body weight and must be determined by your doctor. The usual dose is 12.5 to 25 mg per kg (5.7 to 11.4 mg per pound) of body weight every six hours; or 16.7 to 33.3 mg per kg (7.6 to 15 mg per pound) of body weight every eight hours. For injection dosage form: Adults, teenagers, and children weighing more than 20 kg (44 pounds) 250 to 500 mg, injected into a vein or muscle every three to six hours. Infants and children weighing up to 20 kg (44 pounds) Dose is based on body weight and must be determined by your doctor. The usual dose is 12.5 mg per kg (5.7 mg per pound) of body weight, injected into a vein or muscle every six hours. For bacampicillin: For bacterial infections: For oral dosage forms (oral suspension and tablets): Adults, teenagers, and children weighing more than 25 kilograms (kg) (55 pounds) 400 to 800 milligrams (mg) every twelve hours. Children weighing up to 25 kg (55 pounds) Bacampicillin tablets are not recommended for use in children weighing up to 25 kg (55 pounds). The dose of the oral suspension is based on body weight and must be determined by your doctor. The usual dose is 12.5 to 25 mg per kg (5.7 to 11.4 mg per pound) of body weight every twelve hours. For carbenicillin: For bacterial infections: For oral dosage form (tablets): Adults and teenagers 500 milligrams (mg) to 1 gram every six hours. Children Dose must be determined by your doctor. For injection dosage form: Adults and teenagers Dose is based on body weight and must be determined by your doctor. The usual dose is 50 to 83.3 mg per kilogram (kg) (22.8 to 37.9 mg per pound) of body weight, injected into a vein or muscle every four hours. Older infants and children Dose is based on body weight and must be determined by your doctor. The usual dose is 16.7 to 75 mg per kg (7.6 to 34 mg per pound) of body weight, injected into a vein or muscle every four to six hours. For cloxacillin: For bacterial infections: For oral dosage form (capsules and oral solution): Adults, teenagers, and children weighing more than 20 kilograms (kg) (44 pounds) 250 to 500 milligrams (mg) every six hours. Infants and children weighing up to 20 kg (44 pounds) Dose is based on body weight and must be determined by your doctor. The usual dose is 6.25 to 12.5 mg per kg (2.8 to 5.7 mg per pound) of body weight every six hours. For injection dosage form: Adults, teenagers, and children weighing more than 20 kg 250 to 500 mg, injected into a vein every six hours. Infants and children weighing up to 20 kg (44 pounds) Dose is based on body weight and must be determined by your doctor. The usual dose is 6.25 to 12.5 mg per kg (2.8 to 5.7 mg per pound) of body weight, injected into a vein every six hours. For dicloxacillin: For bacterial infections: For oral dosage form (capsules and oral suspension): Adults, teenagers, and children weighing more than 40 kilograms (kg) (88 pounds) 125 to 250 milligrams (mg) every six hours. Infants and children weighing up to 40 kg (88 pounds) Dose is based on body weight and must be determined by your doctor. The usual dose is 3.1 to 6.2 mg per kg (1.4 to 2.8 mg per pound) of body weight every six hours. For flucloxacillin: For bacterial infections: For oral dosage form (capsules and oral suspension): Adults, teenagers, and children more than 12 years of age and weighing more than 40 kilograms (kg) (88 pounds) 250 to 500 milligrams (mg) every six hours. Children less than 12 years of age and weighing up to 40 kg (88 pounds) 125 to 250 mg every six hours; or 6.25 to 12.5 mg per kg (2.8 to 5.7 mg per pound) of body weight every six hours. Infants up to 6 months of age Dose is based on body weight and must be determined by your doctor. The usual dose is 6.25 mg per kg (2.8 mg per pound) of body weight every six hours. For methicillin: For bacterial infections: For injection dosage form: Adults, teenagers, and children weighing more than 40 kilograms (kg) (88 pounds) 1 gram injected into a muscle every four to six hours; or 1 gram injected into a vein every six hours. Children weighing up to 40 kg (88 pounds) Dose is based on body weight and must be determined by your doctor. The usual dose is 25 milligrams (mg) per kg (11.4 mg per pound) of body weight, injected into a vein or muscle every six hours. For mezlocillin: For bacterial infections: For injection dosage form: Adults and teenagers Dose is based on body weight and must be determined by your doctor. The usual dose is 33.3 to 87.5 milligrams (mg) per kilogram (kg) (15.1 to 39.8 mg per pound) of body weight, injected into a vein or muscle every four to six hours; or 3 to 4 grams every four to six hours. Infants over 1 month of age and children up to 12 years of age Dose is based on body weight and must be determined by your doctor. The usual dose is 50 mg per kg (22.7 mg per pound) of body weight, injected into a vein or muscle every four hours. For nafcillin: For bacterial infections: For oral dosage form (capsules and tablets): Adults and teenagers 250 milligrams (mg) to 1 gram every four to six hours. Older infants and children Dose is based on body weight and must be determined by your doctor. The usual dose is 6.25 to 12.5 mg per kilogram (kg) (2.8 to 5.7 mg per pound) of body weight every six hours. Newborns Dose is based on body weight and must be determined by your doctor. The usual dose is 10 mg per kg (4.5 mg per pound) of body weight every six to eight hours. For injection dosage form: Adults and teenagers 500 mg to 2 grams injected into a vein or muscle every four to six hours. Infants and children Dose is based on body weight and must be determined by your doctor. The usual dose is 10 to 25 mg per kg (4.5 to 11.4 mg per pound) of body weight, injected into a muscle every twelve hours; or 10 to 40 mg per kg (4.5 to 18.2 mg per pound) of body weight, injected into a vein every four to eight hours. For oxacillin: For bacterial infections: For oral dosage form (capsules and oral solution): Adults, teenagers, and children weighing more than 40 kilograms (kg) (88 pounds) 500 milligrams (mg) to 1 gram every four to six hours. Children weighing up to 40 kg (88 pounds) Dose is based on body weight and must be determined by your doctor. The usual dose is 12.5 to 25 mg per kg (5.7 to 11.4 mg per pound) of body weight every six hours. For injection dosage form: Adults, teenagers, and children weighing more than 40 kg (88 pounds) 250 mg to 1 gram injected into a vein or muscle every four to six hours. Children weighing up to 40 kg (88 pounds) Dose is based on body weight and must be determined by your doctor. The usual dose is 12.5 to 25 mg per kg (5.7 to 11.4 mg per pound) of body weight, injected into a vein or muscle every four to six hours. Premature infants and newborns Dose is based on body weight and must be determined by your doctor. The usual dose is 6.25 mg per kg (2.8 mg per pound) of body weight, injected into a vein or muscle every six hours. For penicillin G: For bacterial infections: For oral dosage form (oral solution, oral suspension, and tablets): Adults and teenagers 200,000 to 500,000 Units (125 to 312 milligrams [mg]) every four to six hours. Infants and children less than 12 years of age Dose is based on body weight and must be determined by your doctor. The usual dose is 4167 to 30,000 Units per kilogram (kg) (189 to 13,636 Units per pound) of body weight every four to eight hours. For benzathine injection dosage form: Adults and teenagers 1,200,000 to 2,400,000 Units injected into a muscle as a single dose. Infants and children 300,000 to 1,200,000 Units injected into a muscle as a single dose; or 50,000 Units per kg (22,727 Units per pound) of body weight injected into a muscle as a single dose. For injection dosage forms (potassium and sodium salts): Adults and teenagers 1,000,000 to 5,000,000 Units, injected into a vein or muscle every four to six hours. Older infants and children Dose is based on body weight and must be determined by your doctor. The usual dose is 8333 to 25,000 Units per kg (3788 to 11,363 Units per pound) of body weight, injected into a vein or muscle every four to six hours. Premature infants and newborns Dose is based on body weight and must be determined by your doctor. The usual dose is 30,000 Units per kg (13,636 Units per pound) of body weight, injected into a vein or muscle every twelve hours. For procaine injection dosage form: Adults and teenagers 600,000 to 1,200,000 Units injected into a muscle once a day. Children Dose is based on body weight and must be determined by your doctor. The usual dose is 50,000 Units per kg (22,727 Units per pound) of body weight, injected into a muscle once a day. For penicillin V: For bacterial infections: For the benzathine salt oral dosage form (oral solution): Adults and teenagers 200,000 to 500,000 Units every six to eight hours. Children 100,000 to 250,000 Units every six to eight hours. For the potassium salt oral dosage forms (oral solution, oral suspension, and tablets): Adults and teenagers 125 to 500 milligrams (mg) every six to eight hours. Children Dose is based on body weight and must be determined by your doctor. The usual dose is 2.5 to 16.7 mg per kilogram (kg) (1.1 to 7.6 mg per pound) of body weight every four to eight hours. For piperacillin: For bacterial infections: For injection dosage form: Adults and teenagers 3 to 4 grams, injected into a vein or muscle every four to six hours. Infants and children Dose must be determined by your doctor. For pivampicillin: For bacterial infections: For oral dosage form (oral suspension): Adults, teenagers, and children 10 years of age and older 525 to 1050 milligrams (mg) two times a day. Children 7 to 10 years of age 350 mg two times a day. Children 4 to 6 years of age 262.5 mg two times a day. Children 1 to 3 years of age 175 mg two times a day. Infants 3 to 12 months of age Dose is based on body weight and must be determined by your doctor. The usual dose is 20 to 30 mg per kilogram (kg) (9.1 to 13.6 mg per pound) of body weight two times a day. For oral dosage form (tablets): Adults, teenagers, and children 10 years of age and older 500 mg to 1 gram two times a day. Children up to 10 years of age Dose must be determined by your doctor. For pivmecillinam: For bacterial infections: For oral dosage form (tablets): Adults, teenagers, and children weighing more than 40 kilograms (kg) (88 pounds) 200 milligrams (mg) two to four times a day for three days. Children up to 40 kg (88 pounds) Dose must be determined by your doctor. For ticarcillin: For bacterial infections: For injection dosage form: Adults, teenagers, and children weighing more than 40 kilograms (kg) (88 pounds) 3 grams injected into a vein every four hours; or 4 grams injected into a vein every six hours. Children up to 40 kg (88 pounds) Dose is based on body weight and must be determined by your doctor. The usual dose is 33.3 to 75 milligrams (mg) per kg (15 to 34 mg per pound) of body weight, injected into a vein every four to six hours. Missed Dose If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses. Storage Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing. Keep out of the reach of children. Do not keep outdated medicine or medicine no longer needed. Precautions While Using Bactocill If your symptoms do not improve within a few days, or if they become worse, check with your doctor. Penicillins may cause diarrhea in some patients. Check with your doctor if severe diarrhea occurs. Severe diarrhea may be a sign of a serious side effect. Do not take any diarrhea medicine without first checking with your doctor. Diarrhea medicines may make your diarrhea worse or make it last longer. For mild diarrhea, diarrhea medicine containing kaolin or attapulgite (e.g., Kaopectate tablets, Diasorb) may be taken. However, other kinds of diarrhea medicine should not be taken. They may make your diarrhea worse or make it last longer. If you have any questions about this or if mild diarrhea continues or gets worse, check with your health care professional. Oral contraceptives (birth control pills) containing estrogen may not work properly if you take them while you are taking ampicillin, amoxicillin, or penicillin V. Unplanned pregnancies may occur. You should use a different or additional means of birth control while you are taking any of these penicillins. If you have any questions about this, check with your health care professional. For diabetic patients: Penicillins may cause false test results with some urine sugar tests. Check with your doctor before changing your diet or the dosage of your diabetes medicine. Before you have any medical tests, tell the doctor in charge that you are taking this medicine. The results of some tests may be affected by this medicine. Bactocill Side Effects Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Stop taking this medicine and get emergency help immediately if any of the following effects occur: Less common Fast or irregular breathing fever joint pain lightheadedness or fainting (sudden) puffiness or swelling around the face red, scaly skin shortness of breath skin rash, hives, itching Check with your doctor immediately if any of the following side effects occur: Rare Abdominal or stomach cramps and pain (severe) abdominal tenderness convulsions (seizures) decreased amount of urine diarrhea (watery and severe), which may also be bloody mental depression nausea and vomiting pain at place of injection sore throat and fever unusual bleeding or bruising yellow eyes or skin Rare - For penicillin G procaine only Agitation or combativeness anxiety confusion fear of impending death feeling, hearing, or seeing things that are not real Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them: More common Diarrhea (mild) headache sore mouth or tongue vaginal itching and discharge white patches in the mouth and/or on the tongue Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. Side Effects (complete list) The information contained in the Truven Health Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you. The use of the Truven Health products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Truven Health and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, TRUVEN HEALTH MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Truven Health does not assume any responsibility or risk for your use of the Truven Health products. Copyright 2017 Truven Health Analytics, Inc. All Rights Reserved. Next Side Effects Print this page Add to My Med List More about penicillin v potassium Side Effects During Pregnancy Dosage Information Drug Images Drug Interactions Compare Alternatives Support Group Pricing & Coupons En Espaรฑol 22 Reviews Add your own review/rating Drug class: natural penicillins Consumer resources Penicillin Penicillin V potassium Penicillin V Potassium Oral Solution Penicillin V Potassium Tablets Penicillin Oral, Injection, Intravenous, Intramuscular (Advanced Reading) Other brands: Penicillin VK , Veetids , PC Pen VK Professional resources Penicillin V (AHFS Monograph) ... +4 more Related treatment guides Bacterial Infection Cutaneous Bacillus anthracis Fusospirochetosis, Trench Mouth Clostridial Infection ... +9 more} Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Manufacturers Sandoz Inc. Teva Pharmaceuticals USA, Inc. NorthStar Rx LLC Aurobindo Pharma Limited Hikma Pharmaceuticals PLC More... Drug Class Natural penicillins Related Drugs Bacterial Infection ciprofloxacin , amoxicillin , azithromycin , doxycycline , cephalexin , More... Fusospirochetosis, Trench Mouth Penicillin VK , penicillin v potassium , Pfizerpen , procaine penicillin , More... Skin or Soft Tissue Infection ciprofloxacin , amoxicillin , azithromycin , doxycycline , cephalexin , More... Clostridial Infection metronidazole , Flagyl , Acidophilus , lactobacillus acidophilus , Penicillin VK , Florajen , More... 9 more conditions... Penicillin v potassium Rating 22 User Reviews 7.9 /10 22 User Reviews 7.9 Rate it! Penicillin v potassium Images Penicillin v potassium systemic 500 mg (9 3 1174) View all images Related Questions & Answers Penicillin V Potassium - Is there any way possible to abuse this medication. Concerned? Why does augmentin contain potassium? I have some penicillin v potassium...will it help my abcess teeth?? Can I give my dog Penicillin V potassium 500 mg.for a infection he has? Will Penicillin V Potassium work on abscess tooth? Read more questions} } enormous


easiest way Bactocill traditional